Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Feb
22
2018
Is the Restaurant Trade “Dining Out”? Squire Patton Boggs (US) LLP
Feb
22
2018
FDA oversees destruction and recall of kratom products Keller and Heckman LLP
Feb
21
2018
Amicus Briefs Filed in Support of Deeming Rule Appeal by Washington Legal Foundation, NJOY, CASAA, the State of Iowa and Clive Bates, et al. Keller and Heckman LLP
Feb
21
2018
Maine Recreational Marijuana Law Limits Workplace Drug Testing As Well As Disciplinary Consequences Imposed By Employers Jackson Lewis P.C.
Feb
21
2018
2016 Drug Overdose Death Rate 3-Times Higher than in 1999 Risk and Insurance Management Society, Inc. (RIMS)
Feb
21
2018
No Judges Equals No Judgments: Administrative Confusion at USDA Morgan, Lewis & Bockius LLP
Feb
21
2018
USDA Extends Comment Period for Proposed Rule to “Modernize” Pork Inspection Keller and Heckman LLP
Feb
20
2018
E-Cigarettes Gateway to Conventional Cigarette Smoking Stark & Stark
Feb
20
2018
District Court Issues Opinion in Old Charter Bourbon False Advertising Class Action McDermott Will & Emery
Feb
20
2018
EU Comments on India’s Draft Food Packaging Regulations Keller and Heckman LLP
Feb
20
2018
FDA Updates Spice Risk Profile Keller and Heckman LLP
Feb
20
2018
Federal Enforcement Actions Continue to Focus on Opioid-Related Misconduct Mintz
Feb
20
2018
Are These INOMax Therapeutic Method Claims Directed To A Natural Phenomenon? Foley & Lardner LLP
Feb
20
2018
Over 30% of New Drug Approvals in 2017 were Personalized Medicines Foley & Lardner LLP
Feb
17
2018
JRC Opens Call to Access JRC Nanobiotechnology Laboratory Bergeson & Campbell, P.C.
Feb
16
2018
Pharmaceutical Companies Reportedly Paid $10 Million to Encourage Use of Opioids Clifford Law Offices
Feb
16
2018
White House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices Epstein Becker & Green, P.C.
Feb
16
2018
New EU Regulation Sets BPA Limit in Food-Contact Varnishes and Coatings and Reduces Limit for BPA in Food-Contact Plastic Materials and Articles Keller and Heckman LLP
Feb
16
2018
A Declaration without a Response: Senators Urge DEA to Enact Regulations on Opioid-Based Addiction Treatments Using Telemedicine McDermott Will & Emery
Feb
16
2018
Proposed 2019 Budget Seeks Major Revamp to USDA’s Supplemental Nutrition Assistance Program (SNAP) Keller and Heckman LLP
Feb
16
2018
DOE National Lab Develops Supertough Bioplastic Bergeson & Campbell, P.C.
Feb
15
2018
EPA Increases FIFRA Maximum Civil Penalty Amount Keller and Heckman LLP
Feb
15
2018
Declaration Submitted during IPR from Inventor of Prior Art Confirmed its Inherent Disclosure to Invalidate Monsanto’s Patent Claims Hunton Andrews Kurth
Feb
14
2018
President’s FY 2019 Budget Would Give TTB Criminal Authority over Alcohol McDermott Will & Emery
Feb
14
2018
New DOJ Policy Says Government Lawyers Cannot Base Enforcement Actions on Guidance Documents Keller and Heckman LLP
Feb
14
2018
Opening Brief Filed in Deeming Rule Appeal by Nicopure Labs and the Right to be Smoke-Free Coalition Keller and Heckman LLP
Feb
14
2018
French NGO Claims Many Manufacturers Fail to Comply with Nano Labeling Requirement Bergeson & Campbell, P.C.
Feb
13
2018
FDA Adds 20 New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins